Akorn to Report First Quarter 2019 Financial Results and Host Conference Call
15 avr. 2019 13h56 HE
|
Akorn, Inc.
LAKE FOREST, Ill., April 15, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before...
Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality
21 mars 2019 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 21, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Dandy Dorado-Boladeres has been named as Executive Vice President of Global Quality,...
Akorn Comments on Favorable Court Order
01 mars 2019 17h17 HE
|
Akorn, Inc.
LAKE FOREST, Ill., March 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) announced today that the Delaware Court of Chancery has denied a request by Fresenius Kabi AG to bring a fraud claim...
Akorn Provides Fourth Quarter and Full Year 2018 Results
28 févr. 2019 07h00 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the year ended 2018. ...
Akorn Comments on Fresenius’ Proposed Amended Claims
20 févr. 2019 17h25 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) today announced that it strongly contests Fresenius’ proposed amended claims filed earlier today. Akorn believes these...
Akorn to Report Fourth Quarter and Full Year 2018 Results
11 févr. 2019 16h38 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release...
Akorn Announces New Executive and Board Appointments
28 janv. 2019 16h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), today announced that it has appointed a new executive team member and two new board members. Christopher C. Young...
Akorn Receives FDA Warning Letter
09 janv. 2019 07h55 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4,...
Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 janv. 2019 18h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Akorn granted an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4)...
Akorn Names Douglas S. Boothe as President and CEO
20 déc. 2018 17h05 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Douglas S. Boothe has been named president and chief executive officer effective January 1,...